228 Hematology Molecular Tumor Board (092321)

Dallas, TX US
September 23, 2021

This monthly tumor board meeting will focus on cross collaborations between physicians from the hematopathology team, flow cytometry team, cytogenetic team, molecular pathologists as well as UTSW clinical faculty members in hematologic malignancies. Cases to be discussed will be submitted 1-2 weeks ahead of time in order to prepare bone marrow biopsy data, clinic pathologic and molecular data. We will be reviewing practice data and the impact of molecular testing on clinical decision making and presenting that to the group at the end of the year. This would highlight the importance of molecular testing but also the importance of a multidisciplinary tumor board to interpret the results in the most effective way. This meeting is tentatively scheduled to take place every 4th Thursday of each month (once/mo) for approximately 1 hour.

Target Audience

This activity is appropriate for Malignant hematology clinical faculty members, hematology oncology fellows, hematopathology residents and fellows, hematopathology faculty, and molecular pathology faculty.

Learning Objectives

(1) Discuss hematologic malignancies cases and current recommendations for aiding in clinical decision making.
(2) Recognize and discuss the complexity of molecular tumor testing. 
(3) Identify and discuss how molecular testing can alter treatment decisions
(4) Determine clinically relevant molecular information to incorporate into best practices

Course summary
Available credit: 
  • 1.00 AMA
  • 1.00 Attendance
Course opens: 
09/23/2021
Course expires: 
09/23/2021
Event starts: 
09/23/2021 - 8:00am
Event ends: 
09/23/2021 - 9:00am
Cost:
$0.00
Rating: 
0
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX 75390
United States

Available Credit

  • 1.00 AMA
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.